Founded in April 2010, Hainan Liou Pharmaceutical Co., Ltd. is a wholly-owned pharmaceutical operation enterprise of Tianjin Institute of Pharmaceutical Research, with its headquarters in Tianjin. Adhering to the concept of “opening up the market with enterprising spirit and achieving a win-win situation in the name of good faith”, the company has been committed to the expansion of health undertaking. So far, the company has formed a marketing network covering 33 provincial capitals and economically developed cities in China, and its products have been sold to more than 1100 hospitals at all levels in China. The company mainly sells the products developed by our institute, including Argatroban Injection, Risperidone Tablets, Gliquidone Tablets, Nimesulide Tablets, Glipizide Tablets, etc. Among them, the company’s major product, Argatroban Injection, is clinically recommended in the guidelines of China, America, Japan and other countries as a national key product, and it is an important option for doctors in clinical medication. The company has a young, professional and high-quality talent team, with the employees with bachelor degree or above accounting for about 71% of the total staff. Focusing on the enterprise development plan of marketing innovation and management innovation, the company strives to improve the internal management and expand the market. Its sales performance rises steadily, showing a leap forward development trend.